Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Oncoimmunology|August 21, 2019
High tumoral PD-L1 expression and low PD-1+ or CD8+ tumor-infiltrating lymphocytes are predictive of a poor prognosis in primary diffuse large B-cell lymphoma of the central nervous systemSehui Kim, Soo Jeong Nam, Changhee Park, et al.Thoracic Cancer|September 12, 2019
The efficacy of immune checkpoint inhibitors in anaplastic lymphoma kinase-positive non-small cell lung cancerJa Yoon Heo, Changhee Park, Bhumsuk Keam, et al.JCO Precision Oncology|May 9, 2024
Clinical Validation of Artificial Intelligence-Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non-Small Cell Lung CancerHyojin Kim, Seokhwi Kim, Sangjoon Choi, et al.Translational Lung Cancer Research|March 15, 2021
Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinomaMinsu Kang, Changhee Park, Se Hyun Kim, et al.Plos One|February 9, 2023
Efficacy improvement in searching MEDLINE database using a novel PubMed visual analytic system: EEEvisJong-Chan Lee, Brian J Lee, Changhee Park, et al.ESMO Open|December 6, 2019
Clinical insights on outcomes of corticosteroid administration in immune checkpoint inhibitor-induced pneumonitis by retrospective case series analysisChanghee Park, Bhumsuk Keam, Soon Ho Yoon, et al.Cancers|December 11, 2022
Therapeutic Implications of TGF-β Pathway in Desmoid Tumor Based on Comprehensive Molecular Profiling and Clinicopathological PropertiesKum-Hee Yun, Changhee Park, Hyang Joo Ryu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2024
Clinical Activity of TGF-β Inhibitor Vactosertib in Combination with Imatinib in Desmoid Tumors: A Multicenter Phase Ib/II StudyJin-Hee Ahn, Jeeyun Lee, Changhee Park, et al.Theranostics|September 15, 2020
Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinomaChanghee Park, Kwon Joong Na, Hongyoon Choi, et al.Cancer Immunology, Immunotherapy : CII|November 24, 2020
Pan-cancer methylation analysis reveals an inverse correlation of tumor immunogenicity with methylation aberrancyChanghee Park, Kyeonghun Jeong, Joon-Hyeong Park, et al.Pageof 4